Aguilar-Valles A

Department of Neuroscience, Carleton University, 1125 Colonel By Drive, Ottawa, ON, K1S 5B6, Canada. argel.aguilarvalles@carleton.ca.

6 papers · 1 preprint · ORCID

ArticleKetamine

Sex differences in placebo and antidepressant response to intranasal esketamine for treatment-resistant depression.

Huc M, Siddiqi S, Myers M +4

Europe PMC2026
PreprintKetamine

Sex differences in placebo and antidepressant response to intranasal esketamine for treatment-resistant depression: a pooled participant analysis of randomized controlled trials

Huc M, Siddiqi S, Myers M +4

Europe PMC2025
ArticleKetamine

An integrative view on the cell-type-specific mechanisms of ketamine's antidepressant actions.

Lewis V, Rurak G, Salmaso N +1

Europe PMC2024
ArticlePsilocybin

Beyond the 5-HT<sub>2A</sub> Receptor: Classic and Nonclassic Targets in Psychedelic Drug Action.

Cameron LP, Benetatos J, Lewis V +7

Europe PMC2023
ArticleLSD

A non-hallucinogenic LSD analog with therapeutic potential for mood disorders.

Lewis V, Bonniwell EM, Lanham JK +16

Europe PMC2023
ArticleLSD

Lysergic acid diethylamide (LSD) promotes social behavior through mTORC1 in the excitatory neurotransmission.

De Gregorio D, Popic J, Enns JP +12

Europe PMC2021
ArticlePsilocybin

Hallucinogens in Mental Health: Preclinical and Clinical Studies on LSD, Psilocybin, MDMA, and Ketamine.

De Gregorio D, Aguilar-Valles A, Preller KH +4

Europe PMC2021